introduct
despit
global
success
hib
vaccin
reduc
diseas
mortal
uncertainti
diseas
burden
potenti
impact
hib
vaccin
southeast
asia
delay
introduct
vaccin
countri
region
hib
vaccin
introduc
throughout
vietnam
juli
without
catchup
observ
popul
base
surveil
studi
estim
impact
routin
hib
vaccin
caus
radiolog
confirm
childhood
pneumonia
nha
trang
vietnam
materi
method
activ
hospit
base
surveil
establish
khanh
hoa
gener
hospit
hospit
nha
trang
khanh
hoa
provinc
nasopharyng
sampl
chest
radiograph
taken
routin
children
diagnos
acut
respiratori
ill
admiss
admiss
chest
radiograph
interpret
presenc
primari
endpoint
pneumonia
nasopharyng
swab
analys
pcr
presenc
influenza
b
rsv
rhinoviru
employ
poisson
regress
estim
impact
hib
vaccin
radiolog
confirm
pneumonia
rcp
statist
account
potenti
differ
viral
circul
post
vaccin
era
could
bias
estim
result
case
admit
studi
period
rcp
major
virus
detect
adjust
annual
incid
rcp
children
younger
year
declin
introduct
hib
vaccin
declin
pronounc
children
less
year
old
adjust
irr
signific
impact
observ
year
old
elig
vaccin
adjust
irr
discuss
present
earli
evid
burden
hib
associ
rcp
nha
trang
vaccin
substanti
shortli
introduct
routin
childhood
immunis
scheme
vaccin
substanti
reduc
burden
elsevi
ltd
right
reserv
haemophilu
influenza
type
b
hib
lead
caus
childhood
mortal
morbid
worldwid
hib
estim
caus
million
seriou
case
ill
death
children
common
diseas
manifest
includ
pneumonia
septicemia
mening
world
health
organis
estim
caus
pneumonia
substanti
proport
mening
vari
geograph
could
potenti
prevent
hib
vaccin
henc
recommend
inclus
hib
routin
childhood
immunis
programm
conjug
vaccin
hib
proven
safe
effect
reduc
burden
hib
diseas
variou
set
contrast
region
burden
vaccin
prevent
diseas
associ
hib
southeast
asia
perceiv
low
result
asian
countri
slow
includ
hib
vaccin
routin
schedul
china
thailand
still
introduc
vaccin
increas
bodi
evid
emerg
hib
substanti
contribut
burden
diseas
asia
incid
mortal
associ
hib
southeast
asia
fact
similar
level
observ
mani
part
world
particular
america
includ
recent
find
vietnam
nonbacteraem
episod
hib
pneumonia
thought
substanti
contribut
overal
burden
hib
associ
diseas
unlik
bacteraem
infect
isol
pathogen
blood
provid
wellestablish
evid
diseas
causal
causal
pathogen
nonbacteraem
pneumonia
typic
unknown
gold
standard
diagnost
techniqu
avail
widespread
prehospitalis
use
antibiot
without
prescript
asian
countri
limit
proper
aetiolog
identif
lack
gold
standard
diagnost
techniqu
identifi
pathogen
associ
episod
nonbacteraem
pneumonia
obscur
assess
vaccin
prevent
burden
hib
pneumonia
common
studi
design
furthermor
vaccineunrel
chang
epidemiolog
pathogen
contribut
total
number
pneumonia
case
distort
popul
impact
estim
streptococcu
pneumonia
haemophilu
influeanza
lead
caus
nonbacteraem
pneumonia
supplement
sizeabl
contribut
respiratori
virus
includ
rhinoviru
influenza
respiratori
syncyti
viru
rsv
serotyp
caus
pneumococc
diseas
show
littl
variat
time
absenc
vaccin
serotyp
vari
substanti
preval
time
yet
unknown
reason
like
caus
substanti
amount
pneumonia
despit
low
carriag
rate
similarli
outbreak
size
winter
virus
differ
season
confound
impact
assess
case
control
studi
variou
set
includ
pakistan
bangladesh
report
hib
vaccin
effect
caus
radiolog
confirm
pneumonia
rcp
children
although
methodolog
problem
may
led
inflat
effect
estim
randomis
control
trial
amongst
indonesian
children
could
detect
protect
effect
endpoint
despit
report
substanti
impact
mening
estim
rate
reduct
rcp
commun
routin
use
hib
vaccin
report
amongst
asian
countri
date
support
gavi
allianc
vietnam
includ
hib
part
dtwphibhep
pentaval
quinvaxem
berna
biotech
korea
seoul
south
korea
childhood
immunis
programm
sinc
juli
achiev
dose
coverag
among
children
elig
dose
end
employ
data
activ
hospit
base
surveil
nha
trang
central
vietnam
present
earli
evid
hib
vaccin
vietnam
success
reduc
rate
caus
pneumonia
target
popul
conduct
observ
populationbas
surveil
studi
hospitalis
respiratori
ill
children
year
age
case
assess
chest
radiographi
viral
test
np
specimen
case
rcp
analys
beforeaft
approach
ie
hib
vaccin
introduct
control
secular
trend
common
viral
caus
respiratori
ill
februari
onward
activ
surveil
monitor
hospitalis
case
acut
respiratori
infect
ari
children
conduct
nha
trang
capit
khanh
hoa
provinc
central
vietnam
detail
data
collect
studi
popul
describ
detail
elsewher
briefli
catchment
area
surveil
studi
consist
commun
nha
trang
exclud
increas
rate
foreign
inhabit
children
admit
khanh
hoa
gener
hospit
khgh
februari
march
acut
respiratori
ill
accord
definit
case
cough
andor
difficulti
breath
age
month
month
admiss
resid
catchment
area
enrol
studi
admiss
obtain
inform
consent
parent
guardian
clinic
epidemiolog
inform
collect
respect
paediatrician
nasopharyng
swab
blood
sampl
taken
train
research
nurs
chest
xray
taken
within
h
admiss
chest
xray
read
independ
two
design
radiologist
accord
standard
expert
panel
review
discord
read
sampl
posit
read
khgh
hospit
nha
trang
khanh
hoa
provinc
one
access
resid
catchment
area
henc
incid
calcul
assum
children
rcp
enrol
studi
use
popul
catchment
area
denomin
viral
nucleic
acid
extract
nasopharyng
sampl
four
multiplex
pcr
assay
perform
detect
differ
respiratori
virus
influenza
b
rsv
human
metapneumoviru
hmpv
parainfluenza
viru
piv
rhinoviru
coronavirus
adenoviru
bocaviru
describ
previous
virus
link
pneumonia
children
studi
approv
institut
review
board
nation
institut
hygien
epidemiolog
hanoi
vietnam
institut
review
board
institut
tropic
medicin
nagasaki
univers
nagasaki
japan
present
crude
rel
risk
rr
pneumonia
introduct
hib
vaccin
also
adjust
rr
estim
calcul
adjust
rr
statist
adjust
differ
circul
virus
associ
pneumonia
present
potenti
confound
estim
hib
vaccin
impact
crude
rr
caus
pneumonia
estim
segment
poisson
regress
model
model
regress
monthli
number
case
radiolog
confirm
pneumonia
p
intercept
mark
pre
vaccin
level
factor
p
elsewher
indic
post
vaccin
period
p
e
repres
residu
error
henc
crude
estim
impact
hib
vaccin
childhood
pneumonia
e
calcul
one
minu
chang
log
averag
monthli
number
rcp
introduct
routin
hib
vaccin
beforeaft
design
secular
chang
outcom
rcp
attribut
pathogen
confound
associ
exposur
interest
hib
vaccin
outcom
rcp
address
calcul
adjust
rr
adjust
viral
circul
use
viral
ari
episod
proxi
circul
adjust
rr
nonvir
associ
rcp
nvp
similarli
estim
segment
poisson
regress
model
name
convent
model
addit
attribut
excess
case
rcp
deem
viru
associ
pneumonia
vp
includ
viral
pneumonia
secondari
bacteri
pneumonia
infect
chang
monthli
number
ari
due
influenza
rsv
hmpv
parainfluenza
rhinoviru
adenoviru
bocaviru
n
less
one
case
per
month
averag
influenza
b
parainfluenza
viru
corona
viru
respect
report
pre
vaccin
period
henc
exclud
analysi
limit
occurr
statist
artefact
potenti
neg
associ
virus
pneumonia
rate
omit
ie
presenc
virus
assum
prevent
pneumonia
word
estim
excess
number
rcp
due
influenza
rsv
hpmv
parainfluenza
rhinoviru
adenoviru
bocaviru
obtain
adjust
number
rcp
rcp
exclud
excess
vp
studi
period
base
adjust
number
rcp
nvp
calcul
impact
hib
vaccin
nvp
e
one
minu
chang
log
averag
monthli
number
nvp
introduct
routin
hib
vaccin
multipl
impact
nvp
model
also
correspond
impact
hib
vaccin
rcp
adjust
circul
virus
henc
follow
refer
e
adjust
analysi
adjust
irr
rcp
pneumonia
domin
caus
pneumonia
henc
present
potenti
confound
impact
estim
observ
beforeaft
studi
account
pneumococc
pneumonia
present
potenti
limit
studi
howev
nasopharyng
carriag
major
epidem
pneumococc
serotyp
detect
present
ari
suggest
low
contribut
serotyp
burden
pneumonia
nha
trang
case
miss
inform
viral
test
case
attribut
proport
accord
distribut
ari
case
test
posit
influenza
influenza
b
rsv
rhinoviru
test
neg
respect
month
similarli
ari
episod
chest
radiograph
taken
case
attribut
proport
accord
proport
radiolog
confirm
pneumonia
respect
month
twotail
ttest
chisquar
test
use
appropri
determin
signific
chang
presenc
clinic
featur
pre
vaccin
era
post
vaccin
era
confid
interv
present
refer
confid
level
statist
analysi
perform
r
total
children
less
year
age
hospitalis
ari
enrol
activ
ari
surveil
februari
march
chest
xray
taken
interpret
case
fig
radiograph
classifi
case
radiolog
confirm
pneumonia
primari
endpoint
radiograph
found
uninterpret
main
burden
radiolog
pneumonia
amongst
year
old
shift
slightli
toward
older
age
post
vaccin
period
see
fig
inform
viral
presenc
nasopharynx
avail
case
ari
least
one
viru
detect
test
isol
tabl
influenza
rsv
rhinoviru
account
isol
influenza
rsv
common
among
ari
period
vaccin
see
fig
less
common
virus
includ
hmpv
adenoviru
present
post
vaccin
period
present
potenti
issu
confound
beforeaft
analysi
adjust
studi
particip
present
fever
tabl
common
symptom
includ
dyspnoea
increas
respiratori
rate
rate
antibiot
usag
prior
admiss
chang
significantli
post
vaccin
period
higher
proport
children
found
posit
rcp
present
increas
respiratori
rate
chest
wall
indraw
stridor
fever
children
found
rcp
neg
chang
clinic
featur
toward
milder
symptom
observ
period
introduct
hib
vaccin
similar
rcp
posit
neg
case
averag
annual
incid
radiolog
confirm
childhood
pneumonia
case
per
popul
vaccin
case
per
popul
vaccin
fig
averag
annual
incid
radiolog
confirm
pneumonia
adjust
viral
circul
nvp
children
younger
year
declin
case
per
children
case
per
children
introduct
hib
vaccin
tabl
correspond
reduct
nvt
also
caus
rcp
introduct
routin
childhood
vaccin
hib
coincid
decreas
case
acut
respiratori
ill
rsv
detect
howev
parainfluenza
viru
type
adenoviru
found
fig
c
rsv
estim
increas
nvp
incid
start
hib
vaccin
parainfluenza
viru
type
adenoviru
found
increas
nvp
incid
vaccin
see
fig
correl
cocircul
remain
virus
rcp
found
age
group
children
older
year
elig
vaccin
studi
period
henc
protect
direct
vaccin
effect
find
signific
reduct
rcp
incid
amongst
year
old
children
howev
childhood
pneumonia
burden
children
age
year
annual
rcp
incid
case
per
children
vaccin
tabl
age
group
estim
substanti
declin
pre
vaccin
rcp
incid
case
per
popul
vaccin
correspond
reduct
present
earli
estim
impact
hib
vaccin
caus
pneumonia
observ
popul
base
surveil
studi
children
less
five
year
age
account
differ
viral
circul
pre
post
vaccin
era
find
earli
evid
within
month
introduct
hib
vaccin
burden
caus
pneumonia
children
less
year
age
nha
trang
alreadi
substanti
reduc
howev
small
signific
reduct
rcp
older
children
elig
routin
vaccin
observ
studi
assess
effect
hib
vaccin
rcp
even
fewer
asia
date
studi
conduct
asia
report
effect
estim
casecontrol
design
rather
popul
base
incid
impact
vaccin
effect
estim
brazil
children
receiv
three
vaccin
dose
colombia
gambia
chile
ukrain
pakistan
gambia
chile
case
control
studi
vaccin
prevent
proport
rcp
case
control
studi
bangladesh
use
commun
hospit
control
respect
howev
case
control
design
may
overestim
vaccin
effect
vaccin
unvaccin
commun
differ
significantli
risk
pneumonia
studi
detect
impact
amongst
children
randomis
control
trial
conduct
indonesia
although
signific
impact
mening
nonradiolog
pneumonia
shown
studi
find
suggest
routin
childhood
hib
vaccin
associ
signific
reduct
burden
radiolog
tabl
demograph
clinic
featur
enrol
case
number
posit
report
along
proport
case
appropri
mean
standard
deviat
report
instead
inform
clinic
featur
report
reduc
sampl
size
complet
report
given
nonrcp
definit
chest
indraw
child
chest
wall
move
retract
inhal
increas
respiratori
rate
children
younger
month
defin
least
breath
per
minut
children
month
old
least
breath
per
minut
children
older
month
least
breath
per
minut
antibiot
usag
within
day
prior
admiss
recognis
possibl
affect
suscept
bacteri
pneumonia
annual
incid
per
popul
pre
post
hib
vaccin
era
correspond
incid
risk
ratio
result
adjust
adjust
viral
circul
shown
incid
vaccin
incid
vaccin
incid
risk
ratio
note
unadjust
incid
refer
caus
rcp
adjust
incid
refer
nonviru
associ
rcp
also
mean
incid
present
assum
poisson
distribut
count
data
henc
lower
previous
report
estim
assum
normal
distribut
count
confirm
pneumonia
young
children
vietnam
support
presenc
high
burden
hib
pneumonia
vietnam
absenc
vaccin
high
impact
routin
vaccin
dtwphibhep
lack
measur
impact
hib
vaccin
children
year
age
old
vaccin
may
suggest
herd
protect
establish
yet
subsequ
year
could
benefit
unvaccin
children
hospitalis
acut
respiratori
symptom
classifi
primari
endpoint
pneumonia
accord
definit
studi
substanti
less
respect
fraction
rcp
case
among
hospitalis
children
studi
reflect
low
threshold
admiss
children
respiratori
infect
part
vietnam
free
charg
health
insur
children
age
year
good
access
hospit
within
studi
area
child
polici
vietnam
like
contribut
low
threshold
admiss
therefor
inclus
studi
henc
low
proport
rcp
case
among
rcp
incid
vietnam
low
comparison
middl
incom
set
estim
annual
case
rcp
per
popul
children
less
year
age
alreadi
prevent
yet
immatur
hib
vaccin
programm
estim
avail
vaccin
prevent
burden
sever
nonbacteraem
pneumonia
associ
hib
lack
sensit
specif
diagnost
randomis
trial
conduct
chile
report
burden
vaccin
prevent
rcp
due
hib
per
children
age
month
review
global
burden
hib
estim
southeast
asia
vaccin
prevent
burden
hib
mening
clinic
pneumonia
case
per
children
year
age
respect
sever
instanc
chose
assumpt
estim
may
led
estim
true
impact
hib
vaccin
rcp
ie
conserv
assumpt
absenc
catch
campaign
larg
proport
individu
younger
year
age
elig
vaccin
month
vaccin
introduct
consid
henc
earli
estim
impact
routin
hib
vaccin
may
underestim
full
impact
hib
vaccin
although
hib
pneumonia
like
occur
first
year
increas
durat
follow
transit
period
includ
regress
model
account
initi
period
low
vaccin
elig
consid
age
group
provid
estim
full
impact
hib
vaccin
b
assum
reduct
viru
circul
among
children
present
acut
respiratori
symptom
associ
hib
vaccin
howev
observ
declin
could
partli
due
reduct
coinfect
virus
hib
case
crude
estim
would
accur
estim
actual
impact
hib
vaccin
rcp
c
decreas
sever
symptom
children
diagnos
rcp
khanh
hoa
gener
hospit
post
vaccin
period
could
suggest
increas
health
care
seek
children
milder
symptom
could
led
increas
number
acut
respiratori
case
rcp
report
time
particular
overrepresent
ari
post
vaccin
era
hand
could
reflect
rapid
disappear
sever
childhood
pneumonia
associ
improv
care
seek
overal
socioeconom
develop
test
linear
regress
model
found
evid
signific
decreas
rcp
incid
pre
vaccin
era
account
possibl
chang
pneumococc
pneumonia
particular
due
volatil
serotyp
subset
pre
vaccin
period
serotyp
carriag
children
present
ari
detect
suggest
low
contribut
type
pneumonia
period
bia
would
like
underestim
impact
hib
vaccin
evid
avail
allow
assess
circul
pneumococc
serotyp
henc
potenti
bias
studi
period
howev
previou
studi
find
evid
serotyp
caus
invas
pneumococc
diseas
vietnam
decad
end
impact
may
gener
low
set
henc
unlik
greatli
impact
estim
howev
set
serotyp
domin
eg
africa
adjust
essenti
among
nonrcp
ari
case
antibiot
usag
week
prior
hospit
admiss
increas
post
vaccin
era
henc
potenti
reduc
likelihood
develop
rcp
also
likelihood
develop
rcp
admiss
potenti
reduc
post
vaccin
era
time
ill
onset
hospitalis
decreas
chang
antibiot
usag
timeli
health
care
seek
could
led
overestim
impact
hib
vaccin
analysi
howev
antibiot
usag
timeli
health
care
seek
similar
rcp
case
ari
case
without
rcp
suggest
factor
modest
impact
develop
rcp
case
admit
acut
respiratori
symptom
studi
popul
furthermor
introduct
hib
vaccin
find
littl
chang
rcp
incid
year
old
children
elig
vaccin
studi
period
tent
suggest
observ
impact
among
less
year
old
children
vaccin
specif
potenti
chang
treatment
healthcar
seek
behaviour
popul
littl
impact
rcp
incid
regress
analysi
includ
sever
assumpt
limit
neg
associ
viral
circul
rcp
permit
viru
associ
ill
extens
treat
antibiot
circul
virus
could
prevent
rather
support
effect
bacteri
pneumonia
nevertheless
influenza
rsv
rhinoviru
gener
found
increas
risk
pneumonia
howev
could
find
season
increas
circul
influenza
b
associ
concurr
increas
radiolog
confirm
pneumonia
fig
furthermor
limit
number
case
allow
monthli
resolut
data
henc
possibl
lag
viral
infect
associ
secondari
bacteri
pneumonia
account
moreov
influenza
subtyp
differenti
analysi
subtyp
associ
significantli
differ
risk
pneumonia
could
mask
true
contribut
subtyp
vp
also
adequaci
chest
radiograph
gold
standard
pneumonia
diagnosi
may
question
howev
use
multipl
independ
reader
minimis
nonspecif
test
sensit
result
choic
model
instead
limit
virus
model
suffici
high
detect
frequenc
includ
virus
model
correspond
incid
risk
ratio
children
less
two
year
age
estim
although
signific
trend
found
prior
vaccin
estim
effect
hib
vaccin
children
less
year
age
via
crude
analysi
adjust
linear
trend
pre
post
vaccin
era
correspond
incid
risk
ratio
estim
furthermor
exclud
period
februari
februari
analysi
assess
whether
period
increas
rcp
incid
could
confound
analysi
exclud
period
estim
incid
risk
ratio
children
less
two
year
old
henc
substanti
impact
hib
vaccin
caus
primari
endpoint
pneumonia
nha
trang
rel
robust
model
choic
studi
provid
evid
less
year
introduct
routin
vaccin
hib
vietnam
substanti
impact
caus
rcp
children
less
year
old
observ
driven
children
year
age
vaccin
although
underli
secular
trend
rule
studi
add
bodi
evid
prevent
burden
hib
pneumonia
asian
countri
may
substanti
post
vaccin
surveil
data
need
provid
robust
estim
detect
evid
herd
protect
wje
partner
work
gsk
ekm
serv
advisori
board
gsk
author
declar
compet
interest
studi
support
japan
initi
global
research
network
infecti
diseas
jgrid
mext
japan
japan
societi
promot
scienc
japan
gavi
hib
initi
project
london
school
hygien
tropic
medicin
studi
sponsor
role
studi
design
collect
analysi
interpret
data
write
report
decis
submit
manuscript
public
